Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Paul Miller, certified public accountant and founder of Miller & Company LLP, joined Cheddar News to discuss what electric vehicle owners should know about tax credits and the new rules to qualify for them. "I would definitely make a phone call to your accountant ... to your CPA to ensure that you're getting the credit and it's applicable," he said.
Ed Egilinsky, Managing Director, Head of Sales and Distribution & Alternatives at Direxion, joins Cheddar News to discuss how traders are reacting to bank earnings, and how traders can take advantage of artificial intelligence.
Laura Coccaro, chief people officer at iCIMS, a cloud-based human resources and recruiting software company, talks about how new graduates can get their dream job.
New supervisors leading Disney World’s revamped governing body say they had good intentions about collaborating with the company after they were appointed by Florida Gov. Ron DeSantis.
